| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6199947 | Ophthalmology | 2014 | 8 Pages |
Abstract
Paraproteinemic maculopathy can be unilateral. Decreasing the blood immunoglobulin level is the primary goal of therapy for paraproteinemic maculopathy, and this can be achieved by a systemic route. Coexisting diabetes facilitates leakage of immunoglobulins at lower levels than in nondiabetics.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Ahmad M. MD, J. Fernando MD, Josep MD, Ramana S. MD, Gaurav K. MD, Hernando MD, Jose S. MD, Abdulrazzak PhD, Luis MD, Alejandro Jose MD, Antonio MD, Baseer MD, Joshua G. MD, Antonio MD, Giovanni MD,